Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro

Journal of General Virology

Volumn 95, Issue PART 6, 2014, Pages 1307-1319

  Chivero, Ernest T ^a,b   Bhattarai, Nirjal ^a,b   Rydze, Robert T ^b,f   Winters, Mark A ^c,d   Holodniy, Mark ^c,d   Stapleton, Jack T ^a,b,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD19 ANTIGEN; CD56 ANTIGEN; VIRUS RNA;

ADULT; AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ANTIVIRAL THERAPY; ARTICLE; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL TYPE; EFFECTOR CELL; EXOSOME; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; HUMAN PEGIVIRUS; IN VITRO STUDY; LIMIT OF DETECTION; MALE; MEMORY CELL; MIDDLE AGED; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SERUM; T LYMPHOCYTE SUBPOPULATION; VIRION; VIRUS GENOME; VIRUS PARTICLE; YOUNG ADULT;

ADULT; AMINO ACID SEQUENCE; B-LYMPHOCYTES; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CONSERVED SEQUENCE; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONOCYTES; PHYLOGENY; RNA HELICASES; RNA, VIRAL; SERINE ENDOPEPTIDASES; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE; YOUNG ADULT;

EID: 84900853251     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.063016-0     Document Type: Article

References (52)

1. Adams, M. J., King, A. M. Q. & Carstens, E. B. (2013). Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013). Arch Virol 158, 2023-2030.
2. Agnello, V., Abel, G., Elfahal, M., Knight, G. B. & Zhang, Q. X. (1999). Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96, 12766-12771.
3. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. & Walter, P. (2002). Molecular Biology of the Cell, 4th edn. New York: Garland Science.
4. Berg, T., Müller, A. R., Platz, K. P., Höhne, M., Bechstein, W.-O., Hopf, U., Wiedenmann, B., Neuhaus, P. & Schreier, E. (1999). Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication. Hepatology 29, 245-249.
5. Bhattarai, N. & Stapleton, J. T. (2012). GB virus C: the good boy virus? Trends Microbiol 20, 124-130.
6. Bhattarai, N., Rydze, R. T., Chivero, E. T. & Stapleton, J. T. (2012a). GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. J Infect Dis 206, 1469-1472.
7. Bhattarai, N., McLinden, J. H., Xiang, J., Kaufman, T. M. & Stapleton, J. T. (2012b). GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways. J Immunol 189, 2211-2216.
8. Bhattarai, N., McLinden, J. H., Xiang, J., Landay, A. L., Chivero, E. T. & Stapleton, J. T. (2013). GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. J Immunol 190, 6351-6359.
9. Fan, X., Xu, Y., Solomon, H., Ramrakhiani, S., Neuschwander-Tetri, B. A. & Di Bisceglie, A. M. (1999). Is hepatitis G/GB virus-C virus hepatotropic? Detection of hepatitis G/GB virus-C viral RNA in liver and serum. J Med Virol 58, 160-164.
10. Fogeda, M., Navas, S., Martín, J., Casqueiro, M., Rodríguez, E., Arocena, C. & Carreño, V. (1999). In vitro infection of human peripheral blood mononuclear cells by GB virus C/hepatitis G virus. J Virol 73, 4052-4061.
11. Fogeda, M., López-Alcorocho, J. M., Bartolomé, J., Arocena, C., Martín, M. A. & Carreño, V. (2000). Existence of distinct GB virus C/hepatitis G virus variants with different tropism. J Virol 74, 7936-7942.
12. George, S. L., Xiang, J. & Stapleton, J. T. (2003). Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 316, 191-201.
13. George, S. L., Varmaz, D. & Stapleton, J. T. (2006). GB virus C replicates in primary T and B lymphocytes. J Infect Dis 193, 451-454.
14. George, S. L., Varmaz, D., Tavis, J. E. & Chowdhury, A. (2012). The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression. PLoS ONE 7, e30653.
15. Haase, A. T. (1999). Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol 17, 625-656.
16. Heringlake, S., Ockenga, J., Tillmann, H. L., Trautwein, C., Meissner, D., Stoll, M., Hunt, J., Jou, C., Solomon, N. & other authors (1998). GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 177, 1723-1726.
17. Jung, S., Eichenmüller, M., Donhauser, N., Neipel, F., Engel, A. M., Hess, G., Fleckenstein, B. & Reil, H. (2007). HIV entry inhibition by the envelope 2 glycoprotein of GB virus C. AIDS 21, 645-647.
18. Kisiel, E., Cortez, K. C., Pawełczyk, A., Ośko, I. B., Kubisa, N., Laskus, T. & Radkowski, M. (2013). Hepatitis G virus/GBV-C in serum, peripheral blood mononuclear cells and bone marrow in patients with hematological malignancies. Infect Genet Evol 19, 195-199.
19. Korber, B. (2000). HIV sequence signatures and similarities. In Computational and Evolutionary Analysis of HIV Molecular Sequences, pp. 55-72. Edited by A. G. Rodgrigo & G. H. Learn. Dordrecht, The Netherlands: Kluwer Academic Publishers.
20. Laskus, T., Radkowski, M., Wang, L. F., Vargas, H. & Rakela, J. (1997). Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol 71, 7804-7806.
21. Madejón, A., Fogeda, M., Bartolomé, J., Pardo, M., González, C., Cotonat, T. & Carreń o, V. (1997). GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D. Gastroenterology 113, 573-578.
22. Maidana-Giret, M. T., Silva, T. M., Sauer, M. M., Tomiyama, H., Levi, J. E., Bassichetto, K. C., Nishiya, A., Diaz, R. S., Sabino, E. C. & other authors (2009). GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS 23, 2277-2287.
23. Meckes, D. G., Jr & Raab-Traub, N. (2011). Microvesicles and viral infection. J Virol 85, 12844-12854.
24. Mellor, J., Haydon, G., Blair, C., Livingstone, W. & Simmonds, P. (1998). Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J Gen Virol 79, 705-714.
25. Mohr, E. L. & Stapleton, J. T. (2009). GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat 16, 757-768.
26. Nunnari, G., Nigro, L., Palermo, F., Attanasio, M., Berger, A., Doerr, H. W., Pomerantz, R. J. & Cacopardo, B. (2003). Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 139, 26-30.
27. Pessoa, M. G., Terrault, N. A., Detmer, J., Kolberg, J., Collins, M., Hassoba, H. M. & Wright, T. L. (1998). Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 27, 877-880.
28. Radkowski, M., Kubicka, J., Kisiel, E., Cianciara, J., Nowicki, M., Rakela, J. & Laskus, T. (2000). Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood 95, 3986-3989.
29. Rey, D., Vidinic-Moularde, J., Meyer, P., Schmitt, C., Fritsch, S., Lang, J. M. & Stoll-Keller, F. (2000). High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 19, 721-724.
30. Rydze, R. T., Bhattarai, N. & Stapleton, J. T. (2012). GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death. Antivir Ther 17, 1271-1279.
31. Saito, S., Tanaka, K., Kondo, M., Morita, K., Kitamura, T., Kiba, T., Numata, K. & Sekihara, H. (1997). Plus-and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. Biochem Biophys Res Commun 237, 288-291.
32. Shimizu, Y. K., Hijikata, M., Kiyohara, T., Kitamura, Y. & Yoshikura, H. (1999). Replication of GB virus C (hepatitis G virus) in interferonresistant Daudi cells. J Virol 73, 8411-8414.
33. Smith, D. B., Bukh, J., Kuiken, C., Muerhoff, A. S., Rice, C. M., Stapleton, J. T. & Simmonds, P. (2014). Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 59, 318-327.
34. Souza, I. E., Allen, J. B., Xiang, J., Klinzman, D., Diaz, R., Zhang, S., Chaloner, K., Zdunek, D., Hess, G. & other authors (2006). Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia J Clin Microbiol 44, 3105-3113.
35. Stapleton, J. T., Chaloner, K., Zhang, J., Klinzman, D., Souza, I. E., Xiang, J., Landay, A., Fahey, J., Pollard, R. & Mitsuyasu, R. (2009). GBV-C viremia is associated with reduced CD4 expansion in HIVinfected people receiving HAART and interleukin-2 therapy. AIDS 23, 605-610.
36. Stapleton, J. T., Foung, S., Muerhoff, A. S., Bukh, J. & Simmonds, P. (2011). The GB viruses: a review and proposed classification of GBVA, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 92, 233-246.
37. Stapleton, J. T., Bukh, J., Muerhoff, A. S., Foung, S. & Simmonds, P. (2012a). Assignment of human, simian and bat pegiviruses (previously described as GBV-A, GBV-C, and GBV-D) as members of a new Genus (Pegivirus) within the Flaviviridae. ICTVOfficial Taxonomy: Updates since the 8th Report. http://talk.ictvonline.org/files/ictv_official_taxonomy_ updates_since_the_8th_report/m/vertebrate-official/4486.aspx.
38. Stapleton, J. T., Chaloner, K., Martenson, J. A., Zhang, J., Klinzman, D., Xiang, J., Sauter, W., Desai, S. N. & Landay, A. (2012b). GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. PLoS ONE 7, e50563.
39. Stapleton, J. T., Martinson, J. A., Klinzman, D., Xiang, J., Desai, S. N. & Landay, A. (2013). GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals. AIDS 27, 1829-1832.
40. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M. & Kumar, S. (2011). MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximumparsimony methods. Mol Biol Evol 28, 2731-2739.
41. Tillmann, H. L., Heiken, H., Knapik-Botor, A., Heringlake, S., Ockenga, J., Wilber, J. C., Goergen, B., Detmer, J., McMorrow, M. & other authors (2001). Infection with GB virus C and reduced mortality among HIVinfected patients. N Engl J Med 345, 715-724.
42. Toyoda, H., Fukuda, Y., Hayakawa, T., Takamatsu, J. & Saito, H. (1998). Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 17, 209-213.
43. Tucker, T. J., Smuts, H. E. M., Eedes, C., Knobel, G. D., Eickhaus, P., Robson, S. C. & Kirsch, R. E. (2000). Evidence that the GBV-C/ hepatitis G virus is primarily a lymphotropic virus. J Med Virol 61, 52-58.
44. Vahidnia, F., Petersen, M., Stapleton, J. T., Rutherford, G. W., Busch, M. & Custer, B. (2012). Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. Clin Infect Dis 55, 1012-1019.
45. Williams, C. F., Klinzman, D., Yamashita, T. E., Xiang, J., Polgreen, P. M., Rinaldo, C., Liu, C., Phair, J., Margolick, J. B. & other authors (2004). Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350, 981-990.
46. Xiang, J., Klinzman, D., McLinden, J., Schmidt, W. N., LaBrecque, D. R., Gish, R. & Stapleton, J. T. (1998). Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 72, 2738-2744.
47. Xiang, J., Wünschmann, S., Schmidt, W., Shao, J. & Stapleton, J. T. (2000). Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 74, 9125-9133.
48. Xiang, J., Wünschmann, S., Diekema, D. J., Klinzman, D., Patrick, K. D., George, S. L. & Stapleton, J. T. (2001). Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345, 707-714.
49. Xiang, J., George, S. L., Wunschmann, S., Chang, Q., Klinzman, D. & Stapleton, J. T. (2004). GB virus C infection inhibits HIV-1 replication by increasing RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 363, 2040-2046.
50. Xiang, J., McLinden, J. H., Chang, Q., Kaufman, T. M. & Stapleton, J. T. (2006). An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci U S A 103, 15570-15575.
51. Xiang, J., McLinden, J. H., Kaufman, T. M., Mohr, E. L., Bhattarai, N., Chang, Q. & Stapleton, J. T. (2012). Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology 430, 53-62.
52. Zhang, W., Chaloner, K., Tillmann, H. L., Williams, C. F. & Stapleton, J. T. (2006). Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med 7, 173-180.